Organon (MIL:1OGN) Total Long-Term Assets : €7,079 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Organon Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Organon's Total Long-Term Assets for the quarter that ended in Mar. 2024 was €7,079 Mil.

Organon Total Long-Term Assets Historical Data

The historical data trend for Organon's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Total Long-Term Assets Chart

Organon Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Long-Term Assets

Get a 7-Day Free Trial

5,933.70

5,377.52

6,125.09

6,630.66

6,923.35

Organon Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Long-Term Assets	Get a 7-Day Free Trial														6,522.12	6,480.38	6,523.39	6,923.35	7,079.40

Organon Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Organon Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Organon's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Organon (MIL:1OGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (MIL:1OGN) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

OGN:USA OGN:Mexico 0A9W:UK 7XP:Germany

Address

30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302

Website

https://www.organon.com

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada.

Organon (MIL:1OGN) Headlines

No Headlines